Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FDA5Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,967
Award facts
- Contract value 100% obligated
- $41,967.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 20, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $41,967.07 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) for the supply of Otezla 30 mg tablets in a quantity of 60 units. This firm fixed-price delivery order, with an ultimate completion date of January 21, 2026, was competitively awarded with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate office headquarters. Otezla (apremilast) is a systemic immunosuppressant used to treat psoriasis and psoriatic arthritis, and this delivery order reflects the company's ongoing role in supplying specialty pharmaceutical products to federal healthcare systems.
This delivery order was issued under Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc., also holds a significant IDC with DLA valued up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. Through these IDCs, Amerisourcebergen supplies a diverse portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FDA5Q?
SPE2DR26FDA5Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FDA5Q worth?
The government has obligated $41,967 on SPE2DR26FDA5Q.
Is contract SPE2DR26FDA5Q an order under another contract?
Yes. SPE2DR26FDA5Q is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDA5Q competed?
The extent of competition for SPE2DR26FDA5Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award